testDec 9, 2020
Chancellor Don Elliman welcomed nearly 2,000 guests to the livestream, noting the campus response has been strong. “We have risen again and again to meet the needs of the ever-changing healthcare landscape,” he said. “As we experience another wave of COVID-19 across the country, we are fortunate on this campus to have such talented leaders.”
The panel featured Michelle Barron, MD, professor of infectious diseases; Thomas Campbell, MD, professor of infectious diseases and associate director of clinical research; Elizabeth Carlton, PhD, associate professor of environmental and occupational health; Thomas Flaig, MD, vice chancellor for research; and Adit Ginde, MD, professor of emergency medicine.
These experts brought unique perspectives on topics including deepening our understanding of infectious diseases, the realities of patient care on the front lines, vaccine development and clinical trials, and the modeling efforts informing our state’s response.
Among the advantages noted was the spirit of altruism demonstrated by the outpouring of patients and families affected by COVID-19 who volunteered to be a part of clinical trials. In addition, a modeling team from campus is working closely with state officials to inform policy and slow the spread of the disease and the rise of hospitalization rates.
Chancellor Elliman thanked the generous community of supporters whose philanthropic support has helped bolster the campus response to shifting circumstances and allowed CU Anschutz to pursue expedited research into the causes, treatment and prevention of COVID-19.
Guest contributor: Courtney Keener, Office of Advancement